EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis - Gainor, JF; Shaw, AT; Sequist L, V (Clin Cancer Res, 2016)